TRVI - Trevi Therapeutics Inc.'s (TRVI) CEO Jennifer Good on Q4 2021 Results - Earnings Call Transcript

Trevi Therapeutics, Inc. (TRVI) Q4 2021 Earnings Conference Call March 17, 2022, 04:30 PM ET Company Participants Jennifer Good - President and Chief Executive Officer William Forbes - Chief Development Officer Lisa Delfini - Chief Financial Officer Conference Call Participants Annabel Samimy - Stifel Nathan Weinstein - Aegis Capital Presentation Operator Good afternoon, and welcome to the Trevi Therapeutics Q4 and Year End 2021 Earnings Conference Call. At this time, all participants will be in listen-only mode. [Operator Instructions] After today's presentation there will be an opportunity to ask questions. [Operator Instructions] Please note this event is being recorded. Various remarks the management makes during this call about the company's future expectations, plans, and prospects constitute forward-looking statements for purposes of the Safe Harbor provisions under the Private Securities Litigation Reform Act of 1995. Actual results may differ materially from those indicated by these forward-looking statements as a result of

For further details see:

Trevi Therapeutics, Inc.'s (TRVI) CEO Jennifer Good on Q4 2021 Results - Earnings Call Transcript